My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

SomaLogic, Inc. - Class A Common Stock (NQ:SLGC)

N/A UNCHANGED
Last Price Updated: 4:00 PM EST, Jan 5, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about SomaLogic, Inc. - Class A Common Stock

< Previous 1 2 Next >
Madryn Asset Management Demands SomaLogic’s Board Address Repeated, Unprecedented Adjournments of Tainted Special Meeting
From Madryn Asset Management, LP
Via Business Wire
Madryn Asset Management Addresses SomaLogic’s Apparent Failure to Obtain Requisite Shareholder Support for the Proposed Merger with Standard BioTools
From Madryn Asset Management, LP
Via Business Wire
Proxy Advisory Firm Egan-Jones Recommends SomaLogic Shareholders Vote Against Proposed Merger with Standard BioTools
From Madryn Asset Management, LP
Via Business Wire
Madryn Asset Management Highlights Increasing Public Shareholder Opposition to Value-Destructive SomaLogic Merger and Calls on Company to Make Additional Disclosures
From Madryn Asset Management, LP
Via Business Wire
Madryn Asset Management Releases Evidence That SomaLogic Ran a Flawed and Incomplete Review of Alternatives
From Madryn Asset Management, LP
Via Business Wire
Madryn Asset Management Sends Letter to ISS Respectfully Requesting it Withdraw “Cautionary Support” for SomaLogic’s Value-Destructive Proposed Merger with Standard BioTools
From Madryn Asset Management, LP
Via Business Wire
Madryn Asset Management Reiterates Alternative Path to SomaLogic’s Value-Destructive Proposed Merger with Standard BioTools
From Madryn Asset Management, LP
Via Business Wire
ISS Recommends SomaLogic Stockholders Vote “FOR” Proposed Merger with Standard BioTools
Company Urges Stockholders to Vote “FOR” Value Maximizing Transaction at Upcoming Special Meeting 
From SomaLogic
Via GlobeNewswire
Madryn Asset Management Highlights Newly-Disclosed Conflicts of Interest Related to Proposed SomaLogic Merger with Standard BioTools
From Madryn Asset Management, LP
Via Business Wire
SomaLogic Issues Letter to Stockholders Reiterating Recommendation for Value Maximizing Merger with Standard BioTools
From SomaLogic
Via GlobeNewswire
Madryn Asset Management Issues Letter to Shareholders Correcting False and Misleading Statements in SomaLogic’s Recent Investor Presentation
From Madryn Asset Management, LP
Via Business Wire
Skye Fund III Issues Letter Regarding Opposition to SomaLogic’s Proposed Merger with Standard BioTools
From Skye Fund III, LLC
Via GlobeNewswire
Madryn Asset Management Issues Presentation Detailing Why SomaLogic Shareholders Should Vote “AGAINST” the Value-Destructive and Deeply Flawed Proposed Merger with Standard BioTools
From Madryn Asset Management, LP
Via Business Wire
Lowey Dannenberg, P.C. is Investigating Proposed Merger Between Standard BioTools Inc. (NASDAQ: LAB) and SomaLogic, Inc. (NASDAQ: SLGC)
From Lowey Dannenberg, P.C.
Via GlobeNewswire
Madryn Asset Management, a Top Shareholder of SomaLogic, Issues Letter Regarding Opposition to the Company’s Proposed Merger with Standard BioTools
From Madryn Asset Management, LP
Via Business Wire
Lowey Dannenberg, P.C. is Investigating Proposed Merger Between Standard BioTools Inc. (NASDAQ: LAB) and SomaLogic, Inc. (NASDAQ: SLGC)
From Lowey Dannenberg, P.C.
Via GlobeNewswire
Lowey Dannenberg, P.C. is Investigating Proposed Merger Between Standard BioTools Inc. (NASDAQ: LAB) and SomaLogic, Inc. (NASDAQ: SLGC)
From Lowey Dannenberg, P.C.
Via GlobeNewswire
SomaLogic Reports Recent Business Highlights and Third Quarter 2023 Financial Results
From SomaLogic
Via GlobeNewswire
SomaLogic announces new SomaScan® 11K Platform
Expanded menu gives researchers broadest coverage of the proteome for increased discovery of biomarkers and drug targets 
From SomaLogic
Via GlobeNewswire
SomaLogic to Announce Third Quarter 2023 Financial Results on November 8, 2023
From SomaLogic
Via GlobeNewswire
SLGC Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of SomaLogic, Inc. Is Fair to Shareholders
From Halper Sadeh LLC
Via Business Wire
SomaLogic and Korea’s DNA Link partner to bring the 7,000-plex SomaScan® platform to the fast-growing Asia-Pacific proteomics market
DNA Link will bring the power of the largest proteomics platform available to their biomarker discovery and drug development work 
From SomaLogic
Via GlobeNewswire
SomaLogic researchers identify key proteins to aid in early detection of lung, colon and breast cancer and ovarian tumors
SomaLogic’s SomaScan® platform was used to target 15 markers shared among all cancer types. 
From SomaLogic
Via GlobeNewswire
SomaLogic expands agreement with Novo Nordisk to 2025
Novo Nordisk will extend its use of SomaLogic’s innovative proteomics technologies for research in cardiometabolic and other diseases 
From SomaLogic
Via GlobeNewswire
SomaLogic Reports Second Quarter 2023 Financial Results
From SomaLogic
Via GlobeNewswire
SomaLogic to Announce Second Quarter 2023 Financial Results on August 14, 2023
From SomaLogic
Via GlobeNewswire
SomaLogic partners with Dante Genomics to enhance clinical and research adoption of proteomics in Europe
SomaLogic’s 7,000-plex SomaScan® Platform will be used in proteomics testing at scale in Europe 
From SomaLogic
Via GlobeNewswire
SomaLogic Partners with Citogen to Expand Authorized Site Program in Europe
SomaLogic’s 7,000-plex SomaScan® Platform will be used in clinical research, population health studies and nutrigenomics. 
From SomaLogic
Via GlobeNewswire
SomaLogic Announces Chief Financial Officer Transition
From SomaLogic
Via GlobeNewswire
SomaLogic to Participate in the Jefferies Healthcare Conference
From SomaLogic
Via GlobeNewswire
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.